TTRX Stock Analysis: Buy, Sell, or Hold?
$9.92
+0.13 (+1.33%)
▲
5d:
+4.31%
30d:
-10.71%
90d:
-5.88%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (95%)
Quality Score
58/100
Position
SLIGHTLY LOW
30-Day Fair Range
$9.77 – $11.46
Position: SLIGHTLY LOW
Forward P/E & Valuation
-22.0x
Next 12M consensus est.
Wall Street Target
$25.00
+152.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.20 / $11.55
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: TTRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When TTRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TTRX is currently trading at $9.92, which is considered slightly low relative to its 30-day fair value range of $9.77 to $11.46.
Technical Outlook: Technically, TTRX is in a uptrend. Immediate support is located at $8.20, while resistance sits at $11.55.
Market Sentiment: TTRX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.00 (+152.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TTRX is in a uptrend. Immediate support is located at $8.20, while resistance sits at $11.55.
Market Sentiment: TTRX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.00 (+152.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.77 -
$11.46
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$9.77 -
$11.46
Current vs Trading Range
SLIGHTLY LOW
Support Level
$8.20
Resistance Level
$11.55
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 152.0% below Wall St target ($25.00)
- BULLISH: Bottoming setup score 62/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-22.04
Wall Street Target
$25.00
(+152.0%)
Share TTRX Analysis
Share this live TTRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TTRX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 14, 2026
Daily AI digest
AI Retail Discussion Summary:
Trader @spoppies expresses bullish sentiment towards $TTRX on StockTwits, praising an early investment. No recent news articles were available.
Key Retail Themes:
Early investment
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:06 AM ET
Data refreshes hourly during market hours. Next update: 10:06 AM
Data refreshes hourly during market hours. Next update: 10:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TTRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TTRX Research Pages